The management of patients affected by autoimmune/idiopathic diseases has been revolutionized by the development of targeted therapies (TT). However, the use of TT is complicated by several adverse events, like opportunistic infections (OIs). The potential of TT to predispose to OIs mainly depends on the site of action; nevertheless, such associations are far from being deterministic, because many factors could increase the infection risk.
Targeted therapies for autoimmune/idiopathic nonmalignant diseases: risk and management of opportunistic infections
Bavaro, Davide Fiore;Fiordelisi, Deborah;Angarano, Gioacchino;Saracino, Annalisa
2020-01-01
Abstract
The management of patients affected by autoimmune/idiopathic diseases has been revolutionized by the development of targeted therapies (TT). However, the use of TT is complicated by several adverse events, like opportunistic infections (OIs). The potential of TT to predispose to OIs mainly depends on the site of action; nevertheless, such associations are far from being deterministic, because many factors could increase the infection risk.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Targeted therapies for autoimmune idiopathic nonmalignant diseases risk and management of opportunistic infections.pdf
non disponibili
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright dell'editore
Dimensione
2.08 MB
Formato
Adobe PDF
|
2.08 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
